Minimal requirements for the molecular testing of lung cancer

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F14%3A10288182" target="_blank" >RIV/00179906:_____/14:10288182 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/14:10288182

Výsledek na webu

<a href="http://dx.doi.org/10.3978/j.issn.2218-6751.2014.10.02" target="_blank" >http://dx.doi.org/10.3978/j.issn.2218-6751.2014.10.02</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3978/j.issn.2218-6751.2014.10.02" target="_blank" >10.3978/j.issn.2218-6751.2014.10.02</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Minimal requirements for the molecular testing of lung cancer

Popis výsledku v původním jazyce

From the aspect of the contemporary pathologic diagnostics of lung cancer, it is a key issue of the tissue obtained since small biopsies and cytology still play a major role. In the non-small cell lung cancer era, cytology was considered equal to biopsy.However, in recent years it is unable to provide quality diagnosis and must be replaced by biopsy. Various molecular techniques can handle various different tissue samples which must be considered during molecular pathology diagnosis. Besides, tumor cell-normal cell ratio in the obtained tissue as well as the absolute tumor cell number have great significance and this information must be provided in the primary lung cancer diagnosis. Last but not least, for continuous sustainable molecular diagnosticsof lung cancer rational algorithms, affordable technology and appropriate reimbursement are equally necessary.

Název v anglickém jazyce

Minimal requirements for the molecular testing of lung cancer

Popis výsledku anglicky

From the aspect of the contemporary pathologic diagnostics of lung cancer, it is a key issue of the tissue obtained since small biopsies and cytology still play a major role. In the non-small cell lung cancer era, cytology was considered equal to biopsy.However, in recent years it is unable to provide quality diagnosis and must be replaced by biopsy. Various molecular techniques can handle various different tissue samples which must be considered during molecular pathology diagnosis. Besides, tumor cell-normal cell ratio in the obtained tissue as well as the absolute tumor cell number have great significance and this information must be provided in the primary lung cancer diagnosis. Last but not least, for continuous sustainable molecular diagnosticsof lung cancer rational algorithms, affordable technology and appropriate reimbursement are equally necessary.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

TLCR Translational lung cancer research

ISSN

2218-6751

e-ISSN

—

Svazek periodika

3

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

IN - Indická republika

Počet stran výsledku

4

Strana od-do

301-304

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—